long COVID

A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to the growing body of research on the virus's lasting effects. The finding is being shared with a dose of sarcasm, as some commenters note it confirms what many already suspected about COVID's lingering impact on chronic conditions.

A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to concerns about the lasting effects of infection. The finding points to a broader long-term health burden beyond long COVID itself, with implications for patients managing chronic conditions and for health systems assessing ongoing care needs.

A new study indicates healthcare workers are battling persistent long COVID symptoms, with many continuing to experience fatigue, brain fog and other lasting effects well after infection. The findings highlight the ongoing toll of the pandemic on medical staff, raising concerns about workforce shortages and the need for better support and treatment for affected clinicians.

A new cross-sectional study published in Nature examines the risk factors associated with post-COVID-19 symptoms in patients with asthma and chronic obstructive pulmonary disease. The research aims to identify which characteristics make people with these chronic lung conditions more likely to experience lingering symptoms after infection, a question of ongoing concern for respiratory clinicians.

A US Senate committee has voted to hold Anthony Fauci, the former top US infectious disease official, in contempt of Congress. The vote escalates a long-running standoff between Republican lawmakers and Fauci over documents and testimony connected to the federal response to Covid-19 and the origins of the pandemic. Fauci, who led the National Institute of Allergy and Infectious Diseases for decades before retiring in 2022, remains a frequent target of congressional scrutiny, and the move is likely to deepen partisan fights over pandemic-era decisions.

Ontario is rolling out Covid and flu vaccinations beginning September 28 for priority groups, including hospital patients and staff, people aged 65 and older, and residents and staff of long-term care homes, retirement homes and similar settings. The early access is aimed at protecting the most vulnerable before the wider respiratory illness season, with broader eligibility for the general public expected to follow later.

Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.